Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

273.65
-4.7000-1.69%
Volume:22.78K
Turnover:6.25M
Market Cap:13.06B
PE:-56.06
High:275.39
Open:275.39
Low:272.23
Close:278.35
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.05
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.60
PE(LYR):-93.97

Loading ...

Early notable gainers among liquid option names on August 5th

TIPRANKS
·
Aug 05

Charles River Laboratories International up Nearly 12%, on Track for Highest Close Since April 2024

Dow Jones
·
Aug 05

Movement Alert|Charles River Laboratories Rises 8.32% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

Stock Track | Charles River Laboratories Soars 13.62% Intraday on Q2 Earnings Beat and Raised Profit Forecast

Stock Track
·
Aug 05

Charles River Laboratories International, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Charles River Exec Says Well Positioned to Support Our Acquisition Strategy, We'd Love to be Able to Add a Couple Additional Companies to Our Portfolio - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says There Will Never be a Nams Business for Charles River, Will Always be a Safety Assessment Business Where We're Integrating Nams into Our Safety Assessment Workflows - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says Q3 Adj EPS Expected at $2.90-$3.00 - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says Continue to Expect Lower Volumes for Research Models in North America, Spending from Academic and Government Clients Has Been Constrained by Flat Nih Budgets and Slower Grant Processing - Conf Call

THOMSON REUTERS
·
Aug 05

U.S. Stocks on the MOVE-Cencora, Charles River, Twist Bioscience

Reuters
·
Aug 05

Stock Track | Charles River Laboratories Soars 8.15% in Pre-Market on Q2 Earnings Beat and Raised Guidance

Stock Track
·
Aug 05

Movement Alert|Charles River Laboratories Rises 8.06% in Pre-Market Trading, Q2 Earnings Beat Across the Board with Full-Year Guidance Raised

Market Focus
·
Aug 05

Charles River Laboratories Shares up 8.1% Premarket After Co Lifts FY Profit Forecast

THOMSON REUTERS
·
Aug 05

Charles River Lifts Profit Forecast on Improving Biotech Demand

Reuters
·
Aug 05

Charles River Laboratories Tops Q2 Revenue and Profit Estimates

Reuters
·
Aug 05

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS Range $11.15 - $11.45, vs. FactSet Est of $11.11

MT Newswires Live
·
Aug 05

Earnings Flash (CRL) Charles River Laboratories Posts Fiscal Q2 Revenue $1.00B, vs. FactSet Est of $977.2M

MT Newswires Live
·
Aug 05

Charles River Q2 FY26 GAAP EPS Swings to Loss of $(0.03); Revenue Falls 2.7% to $1 Billion

Reuters
·
Aug 05

Charles River Q2 Adjusted EPS USD 3.02 Vs. IBES Estimate USD 2.74

Reuters
·
Aug 05

Charles River Outlook FY Revenue Growth -3.5 to -2.5%

THOMSON REUTERS
·
Aug 05